WHO ICTRP trial
Effect of neuromodulation device in patient suffering from migraine for…
CTRI/2024/12/078283 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2024/12/078283 |
|---|---|
| Public title | Effect of neuromodulation device in patient suffering from migraine for prophylaxis. |
| Scientific title | Efficacy and safety of Nerivio, a remote electrical neuromodulation device, for prophylaxis of episodic and chronic migraine: an open label, multicentric study in Indian population - NIL |
| Primary sponsor | Dr. Reddy Laboratories Ltd |
| Secondary sponsors | Kantar IMRB Contract Research Organization |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | PMS |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: G431- Migraine with aura Health Condition 2: G430- Migraine without aura |
| Interventions | Intervention1: Nerivio™: Nerivio™ is an US FDA-authorized remote electrical neuromodulation (REN) device for the prophylaxis treatment of migraine with or without aura in patients 12 years old or above. The device delivers transcutaneous… |
| Registration date | Dec 18, 2024 |
| Target size | 278 |
| Secondary IDs | DRL-NEU-003, Version 3.0 dated 25/09/2024 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: